CLINICAL_TRIALS
trial_result
· 2025-01-09
Clinical Trial Update: Dose Finding Study of MCI-186 in Acute Ischemic Stroke [Phase 2]
Summary
Phase 2 dose-finding trial of MCI-186 (edaravone) for acute ischemic stroke was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tanabe Pharma Corporation | Conditions: Acute Ischemic Stroke | Phase 2 | Status: TERMINATED | Results posted: 2025-01-09